NEW YORK, April 29, 2025 /PRNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF)'s Diagnostics Accelerator (DxA) today announced a significant investment that will support clinical validation ...
President Donald Trump has boasted in several recent television appearances about his performance on a screening test intended to assess mild cognitive impairment or early dementia. It’s unclear if ...